Ha habido 50 transacciones internas recientes registradas para Indaptus Therapeutics, Inc. (INDP), incluyendo 39 compras y 2 ventas. El total de compras internas fue valorado en $2.81M y el total de ventas internas en $100.73K.
Internos destacados con actividad reciente incluyen Lazar David E., Dai Junyi, Yao Yun. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — INDP
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-23 |
Lazar David E. |
Director |
Venta Informativa |
700,000 |
- |
- |
- |
| 2026-03-23 |
Dai Junyi |
Chief Executive Officer |
Desconocido |
- |
- |
- |
11,250,000 |
| 2026-03-23 |
Yao Yun |
10 Percent Owner |
Desconocido |
- |
- |
- |
41,991,000 |
| 2026-03-23 |
Sino Lion Ventures Ltd |
10 Percent Owner |
Desconocido |
- |
- |
- |
38,895,000 |
| 2026-02-26 |
Mcmurdo Matthew Charles |
Director |
Desconocido |
- |
- |
- |
25,000 |
| 2026-02-26 |
Jabbour Jerome D |
Director |
Desconocido |
- |
- |
- |
- |
| 2026-02-26 |
Jabbour Jerome D |
Director |
Concesión de RSU |
25,000 |
$2.06 |
$51.5K |
25,000 |
| 2026-02-11 |
Meckler Jeffrey A |
Co-chief Executive Officer |
Devolución de Acciones |
12,136 |
$8.30 |
$100.73K |
- |
| 2026-01-20 |
Ben-tzvi Avraham |
Director |
Concesión de RSU |
25,000 |
- |
- |
25,100 |
| 2026-01-08 |
Natan David |
Director |
Desconocido |
- |
- |
- |
- |
| 2026-01-07 |
Natan David |
Director |
Concesión de RSU |
25,000 |
$2.69 |
$67.25K |
25,000 |
| 2025-12-23 |
Ben-tzvi Avraham |
Director |
Concesión de RSU |
25,000 |
$1.95 |
$48.75K |
25,000 |
| 2025-12-22 |
Lazar David E. |
Co-chief Executive Officer |
Desconocido |
- |
- |
- |
- |
| 2025-12-22 |
Ben-tzvi Avraham |
Director |
Desconocido |
- |
- |
- |
100 |
| 2025-12-22 |
Meckler Jeffrey A |
10 Percent Owner, Officer: Co-chief Executive Officer |
Concesión de RSU |
216,617 |
$2.03 |
$439.73K |
229,929 |
| 2025-12-22 |
Linscott Walt Addison |
Chief Operating Officer |
Concesión de RSU |
54,421 |
$2.03 |
$110.47K |
54,426 |
| 2025-12-22 |
Sassi Nir |
Chief Financial Officer |
Concesión de RSU |
26,758 |
$2.03 |
$54.32K |
26,758 |
| 2025-12-22 |
Newman Michael James |
CSO and Director |
Concesión de RSU |
52,204 |
$2.03 |
$105.97K |
101,074 |
| 2025-07-27 |
Meckler Jeffrey A |
Chief Executive Officer |
Concesión de RSU |
6,068 |
$8.30 |
$50.38K |
13,312 |
| 2025-06-10 |
Hayes William B |
Director |
Concesión de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Martell Robert |
Director |
Concesión de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Maddaluna Anthony J |
Director |
Concesión de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Pomerantz Roger |
Director |
Concesión de RSU |
30,000 |
$0.33 |
$9.9K |
30,000 |
| 2025-06-10 |
Karah Hila |
Director |
Concesión de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Gilbert Mark John |
Director |
Concesión de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2024-11-25 |
Meckler Jeffrey A |
CEO and Director |
Concesión de RSU |
42,553 |
$1.05 |
$44.68K |
42,553 |
| 2024-10-09 |
Meckler Jeffrey A |
CEO and Director |
Concesión de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Linscott Walt Addison |
Chief Operating Officer |
Concesión de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Waltzman Roger J. |
Chief Medical Officer |
Concesión de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Sassi Nir |
Chief Financial Officer |
Concesión de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
Concesión de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-08-08 |
Meckler Jeffrey A |
CEO and Director |
Concesión de RSU |
84,932 |
$1.70 |
$144.38K |
84,932 |
| 2024-06-06 |
Hayes William B |
Director |
Concesión de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Martell Robert |
Director |
Concesión de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Maddaluna Anthony J |
Director |
Concesión de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Pomerantz Roger |
Director |
Concesión de RSU |
30,000 |
$2.63 |
$78.9K |
30,000 |
| 2024-06-06 |
Karah Hila |
Director |
Concesión de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Gilbert Mark John |
Director |
Concesión de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-01-22 |
Meckler Jeffrey A |
CEO and Director |
Concesión de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2024-01-22 |
Linscott Walt Addison |
Chief Operating Officer |
Concesión de RSU |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Waltzman Roger J. |
Chief Medical Officer |
Concesión de RSU |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Sassi Nir |
Chief Financial Officer |
Concesión de RSU |
40,000 |
$1.74 |
$69.6K |
40,000 |
| 2024-01-22 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
Concesión de RSU |
43,250 |
$1.74 |
$75.26K |
43,250 |
| 2023-08-14 |
Anderson Glen R. |
10 Percent Owner |
Compra Informativa |
23,934 |
$2.34 |
$56.01K |
1,190,400 |
| 2023-08-11 |
Anderson Glen R. |
10 Percent Owner |
Compra Informativa |
35,064 |
$2.12 |
$74.34K |
1,166,466 |
| 2023-08-10 |
Anderson Glen R. |
10 Percent Owner |
Compra Informativa |
44,354 |
$1.94 |
$86.05K |
1,131,402 |
| 2023-08-07 |
Waltzman Roger J. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-08-07 |
Waltzman Roger J. |
Chief Medical Officer |
Concesión de RSU |
90,000 |
$1.85 |
$166.5K |
90,000 |
| 2023-05-25 |
Hayes William B |
Director |
Concesión de RSU |
12,500 |
$1.82 |
$22.75K |
12,500 |
| 2023-05-25 |
Maddaluna Anthony J |
Director |
Concesión de RSU |
12,500 |
$1.82 |
$22.75K |
12,500 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
